Viral Vector Development Service Market Report TOC - Profshare

Viral Vector Development Service Market by Product Type ( Retroviral Vectors, Lentiviral Vectors, Adenoviral Vectors, Adeno-associated Viral Vectors, vaccinia vector, herpes simplex victor, baculovirus vector) by Application / End User (Pharmaceutical Manufacturers, Biotechnology Companies, Research Institutes) by Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast 2016

Report Description

Table of Contents

Report Inquiry

List of Tables

List of Figures

Table of Contents
    1. Market Overview
      1.1 Product Overview and Scope of Product
      1.2 Global Market of VIRAL VECTOR DEVELOPMENT SERVICE

    2. Market Insights by Product Type
      2.1 Market Revenue by Product Types:
        2.1.1 Table Market Revenue (in million USD) by Product Types (Historic Data)
        2.1.2 Graph Market Revenue ( in million USD) by Product Types (Current & Forecast Data)
        2.1.3 Graph Market Share (%) by Product Types in 2025

      2.2 Market Volume by Product Types:
        2.2.1 Table Market Volume (in million Units) by Product Types (Historic Data)
        2.2.2 Graph Market Volume ( in million Units) by Product Types (Current & Forecast Data)
        2.2.3 Graph Market Share (%) by Product Types in 2025

      2.3 Retroviral Vectors
        2.3.1 Graph Global Retroviral Vectors Revenue (in million USD ) ()
        2.3.2 Graph Global Retroviral Vectors Volume (in million units ) ()
        2.3.3 Table Retroviral Vectors Geographical Analysis

      2.4 Lentiviral Vectors
        2.4.1 Graph Lentiviral Vectors Revenue (in million USD) ()
        2.4.2 Graph Lentiviral Vectors Volume (in million Units ) ()
        2.4.3 Table Lentiviral Vectors Geographical Analysis

      2.5 Adenoviral Vectors
        2.5.1 Graph Adenoviral Vectors Revenue (in million USD) ()
        2.5.2 Graph Adenoviral Vectors Volume (in million Units ) ()
        2.5.3 Table Adenoviral Vectors Geographical Analysis

      2.6 Adeno-associated Viral Vectors
        2.6.1 Graph Adeno-associated Viral Vectors Revenue (in million USD) ()
        2.6.2 Graph Adeno-associated Viral Vectors Volume (in million Units ) ()
        2.6.3 Table Adeno-associated Viral Vectors Geographical Analysis

    3. Market Segment by Applications
      • Pharmaceutical Manufacturers
      • Biotechnology Companies
      • Research Institutes

      3.1 Table Market Revenue (in million USD) by Application (Historic Data)
      3.2 Table Market Revenue (in million USD) by Application (Current & Forecast Data)
      3.3 Market in the Pharmaceutical Manufacturers
        3.3.1 Graph Global Pharmaceutical Manufacturers Revenue (in million USD ) ()
        3.3.2 Table Global Pharmaceutical Manufacturers Geographical Analysis

      3.4 Biotechnology Companies
        3.4.1 Graph Global Biotechnology Companies Revenue (in million USD ) ()
        3.4.2 Table Global Biotechnology Companies Geographical Analysis

      3.5 Research Institutes

    4. Market by Regions
      4.1.1 Global Market Revenue (In Million) and Growth Rate Comparison by Regions (2018-2026)
      4.1. North America VIRAL VECTOR DEVELOPMENT SERVICE Analysis()
        4.1.1 USA
        4.1.2 Canada
        4.1.3 Mexico
      4.2 Europe VIRAL VECTOR DEVELOPMENT SERVICE Revenue Forecast (2018-27)
        4.2.1 UK
        4.2.2 Germany
        4.2.3 France
        4.2.4 Italy
        4.2.5 Rest Of Europe
      4.3 APAC VIRAL VECTOR DEVELOPMENT SERVICE Revenue Forecast (2018- 2026)
        4.3.1 China
        4.3.2 Japan
        4.3.3 India
        4.3.4 Singapore
        4.3.5 Malaysia
        4.3.6 Rest Of APAC
      4.4 Rest Of the World (ROW) Market Revenue Forecast (2018-2026)
        4.4.1 Africa
        4.4.2 Middle East
        4.4.3 South America

    5. Competitive Analysis
      5.1 Kaneka Eurogentec
        5.1.1 Overview :
        5.1.2 Basic Company Information:
        5.1.3 Financial Overview
        5.1.3 Production Overview
        5.1.4 Geography Revenue Mix ( 2018)
        5.1.5Business Revenue Mix
        5.1.6 Recent Development

      5.2 FinVector
        5.2.1 Overview :
        5.2.2 Basic Company Information:
        5.2.3 Financial Overview
        5.2.4 Production Overview
        5.2.5 Geography Revenue Mix ( 2018)
        5.2.6 Business Revenue Mix
        5.2.7 Recent Development

      5.3 Brammer Bio
        5.3.1 Overview :
        5.3.2 Basic Company Information:
        5.3.3 Financial Overview
        5.3.4 Production Overview
        5.3.5 Geography Revenue Mix ( 2018)
        5.3.6 Business Revenue Mix
        5.3.7 Recent Development

      5.4 Cell and Gene Therapy Catapult
        5.4.1 Overview :
        5.4.2 Basic Company Information:
        5.4.3 Financial Overview
        5.4.4 Production Overview
        5.4.5 Geography Revenue Mix ( 2018)
        5.4.6 Business Revenue Mix
        5.4.7 Recent Development

      5.5 FUJIFILM Diosynth Biotechnologies
      5.6 Sanofi
      5.7 Spark Therapeutics
      5.8 Cobra Biologics
      5.9 UniQure and MassBiologics
      5.10 Renova Therapeutics
      5.11 Shenzhen SiBiono GeneTech
      5.12 Thermo Fisher Scientific

    6. Research Findings and Conclusion
      6.1 Research Finding:
      6.2 Conclusion:

    7. Methodology and Data Source
      7.1 Methodology/Research Approach
      7.2 Research Programs/Design
      7.3 Market Size Estimation
      7.4 Market Breakdown and Data Triangulation
      7.5 Data Source
        7.5.1 Secondary Sources
        7.5.2 Primary Sources
      7.6 Disclaimer